Advertisement

Loading...

Generation Bio Co.

GBIO•NASDAQ
Healthcare
Biotechnology
$5.34
$0.00(0.00%)
U.S. Market opens in 15h 26m

Generation Bio Co. (GBIO) Stock Overview

Explore Generation Bio Co.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap36M
P/E Ratio-0.57
EPS (TTM)$-9.37
ROE-0.95%
Fundamental Analysis

AI Price Forecasts

1 Month$5.35
3 Months$8.06
1 Year Target$6.80

GBIO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Generation Bio Co. (GBIO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 37.85, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $6.80.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.57 and a market capitalization of 36M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-1.66%
6-Month Change
-9.95%
Year-to-Date (YTD) Change
-2.02%
1-Year Change
1.71%
3-Year Change
-85.53%
5-Year Change
-98.46%
All-Time (Max) Change
-97.84%

Contact Information

https://generationbio.com
617 655 7500
301 Binney Street, Cambridge, MA, 02142

Company Facts

1,150 Employees
IPO DateJun 12, 2020
CountryUS

Frequently Asked Questions